Objectives: The antioxidant tert-butylhydroquinone (TBHQ) is a food additive reported to have antibacterial activity, and may therefore have application in the healthcare setting. This study sought to characterize the antibacterial activity and mode of action of TBHQ and its oxidation product, tert-butylbenzoquinone (TBBQ).
Introduction
The lipophilic antioxidant tert-butylhydroquinone (TBHQ) (Figure 1a ) was approved for use in the USA as a food preservative in 1972. 1 -3 It has predominantly been employed for the stabilization and preservation of fats and foods with high fat content owing to its radical-scavenging activity. 1, 4 However, TBHQ has also been reported to have antibacterial properties, exhibiting a spectrum of activity that encompasses bacterial species responsible for human disease, including Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Streptococcus mutans and Staphylococcus aureus. 1, 3, 5, 6 In view of its history of safe use in foods and its antibacterial activity, TBHQ has been under consideration for use in healthcare products by Evocutis plc. 7 This study therefore sought to characterize the antibacterial activity of TBHQ, with a particular emphasis on its antistaphylococcal activity, and to determine its mode of action (MOA). An important consideration when seeking to characterize the biological properties of antioxidants is their stability in solution, since they can undergo oxidation to form other chemical species. Because the biological properties of an antioxidant and its breakdown products may differ, care must be taken to relate observed properties to the chemical species present. As TBHQ has most often been used as an additive for vegetable oils, 4 previous studies have examined its stability at temperatures reached in the frying process. At such temperatures (175 -1858C) TBHQ is oxidized primarily to tert-butylbenzoquinone (TBBQ; Figure 1a and b), although smaller quantities of a number of other compounds have been detected, including dimerized TBHQ 8, 9 and free radical species that decompose to alternate # The Author 2013. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com oxidation products ( Figure 1b ). 8 However, the stability of TBHQ has not been examined at temperatures relevant to the study of its antibacterial activity. Consequently, we initiated this work with an investigation into the stability of TBHQ in solution at 378C. We then progressed to a more comprehensive study to examine the microbiological activity and MOA of TBHQ/TBBQ, with a view to determining whether TBHQ might have potential as an agent for use in human healthcare. Laboratory strains of bacteria used in this study are listed in Table 1 . Clinical S. aureus isolates used for susceptibility testing were part of a culture collection belonging to the Antimicrobial Research Centre, University of Leeds, UK. Staphylococci were propagated in Mueller Hinton broth (MHB) and on Mueller Hinton agar (MHA) (Oxoid Ltd, Cambridge, UK); for studies with daptomycin and valinomycin, culture media were supplemented with calcium (50 mg/L, in the form of CaCl 2 ) and potassium chloride (0.1 M), respectively. Strains of E. coli and Bacillus subtilis were grown in Luria-Bertani broth and on Luria-Bertani agar (Oxoid). ) were determined at their absorbance maxima (290 and 252 nm, respectively) 10 using known concentrations of both compounds in PBS. Stability studies were performed at 378C with shaking, using starting concentrations of TBHQ and TBBQ for which absorbance readings could be taken without requiring dilution of the solution (absorbance values of ,0.8); for TBHQ, the concentration used was 385 mM (64 mg/L), and for TBBQ, 97 mM (16 mg/L). The Beer-Lambert law was used to calculate the concentrations of TBHQ and TBBQ present in solution over time.
Materials and methods

Bacterial strains, growth media and chemicals
Stability studies with TBHQ and TBBQ
Antibacterial activity testing
MICs were determined by exposing bacteria to serial dilutions of antibacterial agents in MHB according to CLSI broth microdilution guidelines. MBCs were determined by enumerating bacteria surviving challenge with concentrations of antibacterial agents above the MIC; bacterial colonies were counted after incubation at 378C for 18-24 h on MHA, and the MBC was defined as the minimum concentration of antibacterial agent that caused a 99.9% kill.
12 Biofilm MICs (bMICs) and minimum biofilm eradication concentrations (MBECs) were determined using S. aureus SH1000 biofilms grown using the Calgary Biofilm Device (Nunc, Roskilde, Denmark), as previously described. 13, 14 Time-kill assays were performed using a method adapted from Oliva et al. 15 Briefly, bacteria were cultured to early exponential phase (OD 600 of 0.2) in MHB and challenged with antibacterial agents at 4× MIC. In some instances, bacteria were cultured to early exponential phase, washed and resuspended in PBS pre-warmed to 378C, before exposure to antibacterial agents. Bacterial viability was monitored by plating cultures onto MHA, and enumerating colonies after incubation at 378C for 18-24 h. To detect bacterial lysis following challenge with antibacterial agents, the culture turbidity of early exponential phase cultures was monitored by absorbance measurements at 600 nm at 378C. 
Antibacterial MOA studies
The effect of TBBQ on biosynthesis of DNA, RNA and protein was monitored in early exponential phase cultures of S. aureus SH1000 (OD 600 of 0.2) by following the incorporation of the radiolabelled precursors [methyl-
3 H]thymidine, [5, H]uridine and L-[G-
3
H]glutamine into macromolecules. 16, 17 The action of TBBQ was also investigated using a suite of pathway-specific biosensor strains of B. subtilis that have previously been described for use in MOA studies. 18, 19 The effect of antibacterial compounds on the integrity of the staphylococcal membrane after 10 min exposure was assessed using the BacLight TM assay. 17, 20 The ability of compounds to damage mammalian membranes was examined by measuring the haemolysis of equine erythrocytes. 15 Briefly, lithium heparin-treated whole equine blood (Matrix Biologicals Ltd, Hull, UK) was centrifuged at 1000 g for 10 min at 48C, and the supernatant and buffy coat discarded. The erythrocyte pellet was washed and resuspended to 5% v/v in 10 mM Tris-HCl buffer containing 0.9% NaCl (pH 7.4) at 48C. Erythrocytes were further diluted 25-fold in buffer, and pre-incubated at 378C for 15 min prior to use. Erythrocytes were exposed to a concentration of antibacterial agent equivalent to 4× MIC for S. aureus SH1000 for 1 h at 378C. Mixtures were centrifuged at 3000 g for 5 min; the extent of haemoglobin leakage was measured at OD 540 and expressed as a percentage of that recorded for the positive control (5% SDS).
Results
Stability studies with TBHQ and TBBQ TBHQ maintained in PBS at 378C was found to be unstable, degrading in a pH-and oxygen-dependent manner (Figure 2 ). At neutral pH, this degradation proceeded rapidly, with only 50% remaining after 6 h ( Figure 2a) . Concentrations of TBHQ decreased and TBBQ increased concurrently, indicating that TBHQ was primarily being oxidized to form TBBQ. The rate of degradation of TBHQ was slower at more acidic pH (Figure 2a) , and degradation did not occur under anaerobic conditions (Figure 2b) . Addition of the antioxidant ascorbate, which has previously been shown to inhibit the decomposition of TBHQ at 100 mg/L at room temperature, 21 was able to inhibit the degradation of TBHQ at pH 7 in a concentration-dependent manner (Figure 2c) .
Since TBHQ undergoes rapid oxidation to TBBQ in aqueous solutions, experiments were performed to assess whether this oxidation product is stable in solution. Under aerobic conditions at 378C, TBBQ was found to degrade only slowly and in a pH-independent manner, with 90% of TBBQ remaining after 6 h (Figure 2d) . However, and in contrast to TBHQ, TBBQ was unstable under anaerobic conditions, and its degradation could not be prevented by concentrations of ≤512 mg/L of ascorbate (Figure 2e and f) . The reduction in TBBQ concentration was not accompanied by an increase in TBHQ, indicating that TBBQ must have been undergoing conversion into an alternative product. Since the addition of ascorbate to this product prompted regeneration of TBHQ (Figure 2f ), the TBBQ breakdown product is likely to be the intermediary semiquinone anion radical (Figure 1b) .
Antibacterial activity of TBHQ and TBBQ
TBHQ and TBBQ MICs and MBCs were determined for the S. aureus laboratory strain SH1000, and two commonly used S. aureus susceptibility testing strains (ATCC 23723 and 29213). Our studies on the stability of TBHQ implied that this agent would undergo extensive conversion during the course of a 24 h MIC determination (Figure 2a) , with potential impact on its antibacterial activity. Therefore, we investigated the possibility of stabilizing TBHQ in solution. Since both the absence of oxygen and the addition of ascorbate inhibit degradation of TBHQ, 22 MICs were determined anaerobically and following the addition of ascorbate to the culture media. Under anaerobic conditions, there was an 8-fold increase in TBHQ MIC for S. aureus SH1000, from 8 to 64 mg/L. TBHQ MICs also increased dramatically in the presence of ascorbate, reaching 512 mg/L (a 64-fold increase) upon addition of ascorbate at 1024 mg/L. Therefore, TBHQ lost useful antibacterial activity when spontaneous oxidation of TBHQ to TBBQ was prevented. In contrast, TBBQ retained activity in the absence of oxygen, with only a 2-fold increase in TBBQ MIC observed, and the addition of 1024 mg/mL of ascorbate caused only an 8-fold increase in MIC.
The antibacterial activity of a solution containing the breakdown product of TBBQ was also assessed against S. aureus SH1000, and gave an MIC of 128 mg/L. However, this activity was attributed to the TBBQ remaining in the solution; 10% of the starting TBBQ remained, a concentration of TBBQ that would provide this level of antibacterial activity. Thus, the final breakdown product of TBBQ appears to have little or no antibacterial activity.
TBHQ has been reported to display limited activity against E. coli, 1 and indeed we saw activity only at high concentrations (MICs of 512 mg/L) for TBHQ and TBBQ against E. coli 1411. To explore the reason for the poor activity of this compound against Gram-negative bacteria, we performed susceptibility testing with TBHQ and TBBQ against E. coli in the presence of an outer membrane permeabilizing agent [polymyxin B nonapeptide (PMBN), at a concentration of 4 mg/L] and against efflux pump-deficient strains. 23, 24 The antibacterial activity of TBHQ and TBBQ increased against E. coli strains lacking AcrAB or TolC (256 and 128 mg/L for strains SM1411 and ES100, respectively) and reached a level of activity comparable to that observed against S. aureus (16 mg/L) in the presence of PMBN (MICs of 32 and 16 mg/L for SM1411 and ES100, respectively). The results suggest that the limited activity of the compounds against E. coli is both the result of limited ingress across the outer membrane, and a consequence of active efflux from the cell by AcrAB-TolC.
Evaluation of bacterial killing and lysis by TBHQ and TBBQ
In order to further evaluate the bactericidal activity of TBHQ/ TBBQ, the killing kinetics of these compounds were assessed alongside established antibiotics. Daptomycin caused a reduction in cell viability of 3 log 10 cfu/mL after 6 h in PBS, while tetracycline caused only bacteriostasis (Figure 3a) . TBHQ had no effect on bacterial viability for the first 120 min of the experiment, but killing was observed thereafter (Figure 3a) . The initiation of bacterial killing coincided with the commencement of conversion of TBHQ into TBBQ (Figure 3b) , and the extent of kill increased with rising TBBQ concentration, ultimately leading to a 4 log 10 drop in cell number after 6 h (Figure 3b ). TBBQ showed no initial lag in killing activity and was rapidly and extensively bactericidal, causing a .5 log 10 drop in cell number within 3 h, effectively sterilizing the culture within 6 h. Over this time period, TBBQ degradation was minimal (Figure 3c) .
In nutrient-rich culture medium (MHB), TBHQ/TBBQ displayed reduced activity against S. aureus SH1000 compared with that seen in PBS. Nonetheless, TBBQ retained bactericidal activity in MHB, causing .4 log 10 reduction in viable cell number within 6 h (Figure 4a ). At TBHQ/TBBQ concentrations of up to 256 mg/ L, there was little or no reduction in culture turbidity over a 6 h period (Figure 4b ), indicating that bacterial killing by TBBQ occurred without concomitant cell lysis. 25 
MOA studies on TBHQ and TBBQ
Since MOA studies are an essential part of the pre-clinical evaluation of candidate antibacterial agents, we sought to investigate the MOA of TBHQ and TBBQ using a variety of approaches. Antibacterial agents commonly exert their activity through inhibition of macromolecular biosynthesis pathways. 25 Therefore, we initially examined the effects of TBHQ/TBBQ using a suite of B. subtilis biosensors responsive to the inhibition of specific macromolecular biosynthesis pathways (DNA, RNA, protein, cell wall and fatty acid). 18, 19 No induction was observed with any of the biosensors for TBHQ/TBBQ in the concentration range 0.005-20 mg/L (data not shown). The effect of TBHQ/TBBQ on the incorporation of radiolabelled precursors into staphylococcal macromolecules was compared with known inhibitors of DNA, RNA and protein synthesis (ciprofloxacin, rifampicin and tetracycline, respectively) at 4× MIC. Both TBHQ and TBBQ inhibited all three macromolecular synthetic pathways within 10 min, with no evidence of preferential inhibition of a single biosynthetic process ( Figure 5 ). Rapid bactericidal activity, failure to induce pathway-specific biosensors, and non-specific inhibition of macromolecular synthesis are features common to antibacterial agents that act on bacteria by compromising the integrity of the cytoplasmic membrane (CM). 17 To examine whether TBHQ/TBBQ act on bacterial membranes, we employed the BacLight TM assay. Staphylococcus aureus cells exposed to vancomycin, tetracycline, daptomycin or TBHQ for 10 min retained between 90% and 100% of their membrane integrity, while TBBQ and the known membrane disruptors valinomycin and cetyltrimethylammonium bromide (CTAB) significantly reduced membrane integrity over the same time period (Table 2 ). Since antibacterial compounds that compromise the bacterial membrane may show comparable effects on mammalian membranes, it is important to establish the prokaryotic selectivity of antibacterial candidates with this MOA.
26 Therefore, TBBQ was tested for its ability to cause haemolysis of mammalian erythrocytes. Non-membranedamaging agents caused ,5% loss in erythrocyte integrity, while the known membrane-disruptors valinomycin and CTAB induced haemolysis (Table 2 ). However, TBBQ had little effect on erythrocyte integrity, suggesting that the interaction with cell membranes is prokaryotic-specific (Table 2) .
Discussion
TBHQ and TBBQ both demonstrated potent bactericidal activity against planktonic cells and biofilms of S. aureus. However, several lines of evidence indicate that TBBQ is responsible for the antibacterial activity of TBHQ. Halting the conversion of TBHQ into TBBQ (via the addition of ascorbate or incubation under anaerobic conditions) dramatically reduced antibacterial activity, i.e. TBHQ had little intrinsic antibacterial activity when prevented from undergoing oxidation. This suggests that the antibacterial effect associated with TBHQ either results from the process of conversion of TBHQ into TBBQ (e.g. through the production of reactive intermediates) or is intrinsic to TBBQ. As TBHQ and TBBQ are equally effective at inhibiting bacterial growth (an MIC of 8 mg/L for SH1000 in both cases), the antibacterial activity of TBHQ cannot be attributed to an intermediate species arising from conversion of TBHQ into TBBQ, and must be a property of TBBQ.
Further support for this idea is provided by the time -kill studies. In contrast to TBBQ, TBHQ at 4× MIC does not immediately trigger bacterial killing, but only begins to do so after 2 h (Figure 3b ). This initial lag in killing activity corresponds to the time required for the conversion of sufficient quantities of TBHQ into TBBQ for bacterial killing to occur. Levels of conversion into TBBQ and bacterial cell death increased concurrently over a 6 h period, reaching 40% conversion of TBHQ into TBBQ and more than a 4 log 10 drop in cell number. By contrast, TBBQ initiated bacterial killing immediately and was more active than all comparator antibiotics, leading to .5 log 10 drop in viability within 3 h (Figure 3a) . Degradation of TBBQ was limited during this period, indicating that the process of conversion of TBBQ, or a breakdown product of TBBQ, is not responsible for the lethal effect. Furthermore, the primary breakdown product of TBBQ was shown in separate experiments to possess no or only limited antibacterial activity. In conclusion, TBHQ exhibits antibacterial activity upon degradation and formation of TBBQ; this compound possesses intrinsic antibacterial activity that is then lost upon degradation ( Figure 6 ).
The MOA of TBBQ appears to involve compromising the integrity of the bacterial CM, without causing cell lysis. The observed lack of activity for TBBQ against E. coli suggests that it is unable to damage the outer membrane of Gram-negative bacteria. Nevertheless, since permeabilization of the outer membrane renders E. coli susceptible to TBBQ, the CM of Gram-negative bacteria is susceptible to its action. Importantly, TBBQ appears to display selective action against the bacterial CM, as it did not induce haemolysis of erythrocytes. The fact that TBBQ acts to compromise the integrity of the bacterial membrane may explain why this compound has the ability to eradicate staphylococcal biofilms; potent antibiofilm activity is a property that is often associated with membrane-perturbing agents. 27, 28 In addition to antibiofilm activity, the membraneperturbing MOA of TBBQ may also be advantageous in respect of restricting the selection of bacterial resistance, as there is evidence to suggest that bacteria do not readily acquire resistance to membrane-active agents. 17, 27 In summary, TBBQ is a potent, bactericidal, and apparently selective antistaphylococcal compound that demonstrates the ability to eradicate S. aureus biofilms in vitro; it therefore warrants further investigation as a candidate antistaphylococcal agent for use in the healthcare setting. H thymidine, uridine and glutamine into DNA, RNA and protein, respectively (means of at least three independent replicates; error bars show standard deviations).
